These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer. Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001 [TBL] [Abstract][Full Text] [Related]
4. Near infrared fluorescence imaging of EGFR expression Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Hill W; Parada AC; Fonge H; Geyer CR Oncotarget; 2018 Jan; 9(5):6213-6227. PubMed ID: 29464066 [TBL] [Abstract][Full Text] [Related]
5. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models. Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946 [TBL] [Abstract][Full Text] [Related]
6. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging. Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214 [TBL] [Abstract][Full Text] [Related]
7. Preclinical Evaluation of Hartimath SV; Alizadeh E; Solomon VR; Chekol R; Bernhard W; Hill W; Parada AC; Barreto K; Geyer CR; Fonge H J Nucl Med; 2019 Aug; 60(8):1103-1110. PubMed ID: 30655327 [TBL] [Abstract][Full Text] [Related]
8. Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging. Alam MK; El-Sayed A; Barreto K; Bernhard W; Fonge H; Geyer CR Mol Imaging Biol; 2019 Feb; 21(1):54-66. PubMed ID: 29948640 [TBL] [Abstract][Full Text] [Related]
9. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096 [No Abstract] [Full Text] [Related]
10. Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments. Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Fonge H; Geyer CR Theranostics; 2019; 9(4):974-985. PubMed ID: 30867810 [TBL] [Abstract][Full Text] [Related]
11. Characterizing the detection threshold for optical imaging in surgical oncology. Prince AC; Jani A; Korb M; Tipirneni KE; Kasten BB; Rosenthal EL; Warram JM J Surg Oncol; 2017 Dec; 116(7):898-906. PubMed ID: 28628728 [TBL] [Abstract][Full Text] [Related]
13. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery. Tang C; Du Y; Liang Q; Cheng Z; Tian J Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075 [TBL] [Abstract][Full Text] [Related]
14. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody. Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882 [TBL] [Abstract][Full Text] [Related]
15. A radiopharmaceutical [ Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [ Chan C; Fonge H; Lam K; Reilly RM Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737 [TBL] [Abstract][Full Text] [Related]
17. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers. Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094 [No Abstract] [Full Text] [Related]
18. Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile. Garrido G; Tikhomirov IA; Rabasa A; Yang E; Gracia E; Iznaga N; Fernández LE; Crombet T; Kerbel RS; Pérez R Cancer Biol Ther; 2011 Feb; 11(4):373-82. PubMed ID: 21150278 [TBL] [Abstract][Full Text] [Related]
19. Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo. Nitta Y; Shimizu S; Shishido-Hara Y; Suzuki K; Shiokawa Y; Nagane M Cancer Med; 2016 Mar; 5(3):486-99. PubMed ID: 26778701 [TBL] [Abstract][Full Text] [Related]
20. Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model. Bhuvaneswari R; Ng QF; Thong PS; Soo KC Oncotarget; 2015 May; 6(15):13487-505. PubMed ID: 25918252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]